Global healthcare leader Abbott has introduced its latest diabetes management innovation, the Free Style Libre 2 Plus sensor, in India. The next-generation device provides automatic glucose readings every minute directly to a smartphone, along with optional alarms for high or low sugar levels. This advancement eliminates the need for routine fingersticks, giving people with diabetes more confidence and freedom in managing their health.
India, home to over 101 million people with diabetes—the world’s second-largest population—faces a growing demand for real-time management tools. Abbott’s technology has already transformed care for more than seven million people globally. Studies show FreeStyleLibre technology can reduce low blood sugar episodes by up to 43%, hospital visits by 66%, and significantly cut risks of cardiovascular and stroke-related complications.
In Guwahati, doctors and retailers view the launch as a timely boost to diabetes care. With rising cases across Assam and the Northeast, the availability of advanced continuous glucose monitoring is expected to improve early intervention, reduce hospital dependency, and make diabetes management more accessible to urban as well as semi-urban patients. FreeStyle Libre 2 Plus is available across India for adults and children aged two and above, including women with gestational diabetes.
